X-Linked Agammaglobulinemia (XLA):Phenotype, Diagnosis, and Therapeutic Challenges Around the World

• Autor(a) principal: El-Sayed, ZA
• Data de Publicação: 2019
• Outros Autores: Abramova, I, Aldave, JC, Al-Herz, W, Bezrodnik, L, Boukari, R, Bousfiha, AA, Cancrini, C, Condino-Neto, A, Dbaibo, G, Derfalvi, B, Dogu, Fi, Edgar, JDM, Eley, B, El-Owaidy, RH, Espinosa-Padilla, SE, Galal, N, Haerynck, F, Hanna-Wakim, R, Hossny, E, Ikinciogullari, A, Kamal, E, Kanegane, H, Kechout, N, Lau, YL, Morio, T, Moschese, V, Neves, JF, Ouederni, M, Paganelli, R, Paris, K, Pignata, C, Plebani, A, Qamar, FN, Qureshi, S, Radhakrishnan, N, Rezaei, N, Rosario, N, Routes, J, Sanchez, B, Sediva, A, Seppanen, MR, Serrano, EG, Shcherbina, A, Singh, S, Siniah, S, Spadaro, G, Tang, M, Vinet, AM, Volokha, A, Sullivan, KE
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.17/3249
• topic: Agammaglobulinemia; Autoimmunity; Chronic Lung Disease; Family History; Gastrointestinal; Immunoglobulin; Juvenile idiopathic arthritis; Subcutaneous Immunoglobulin; Vaccine Associated Paralytic Poliomyelitis; XLA, X-Linked Agammaglobulinemia; HDE PED

X-linked agammaglobulinemia is an inherited immunodeficiency recognized since 1952. In spite of seven decades of experience, there is still a limited understanding of regional differences in presentation and complications. This study was designed by the Primary Immunodeficiencies Committee of the World Allergy Organization to better understand regional needs, challenges and unique patient features.